📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Safety and efficacy of C9ORF72 -repeat RNA nuclear export inhibition in amyotrophic lateral sclerosis (2021)

First Author: Castelli L

Attributed to: Novel therapeutic strategies to target RAN translation of pathological C9ORF72 repeat transcripts and associated neurodegeneration funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.04.12.438950

Publication URI: http://dx.doi.org/10.1101/2021.04.12.438950

Type: Preprint